These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 18394801

  • 1. Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.
    Subramanian S, Divya Shree AN.
    Neurosci Lett; 2008 May 09; 436(2):219-22. PubMed ID: 18394801
    [Abstract] [Full Text] [Related]

  • 2. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
    Seabrook TJ, Thomas K, Jiang L, Bloom J, Spooner E, Maier M, Bitan G, Lemere CA.
    Neurobiol Aging; 2007 Jun 09; 28(6):813-23. PubMed ID: 16725229
    [Abstract] [Full Text] [Related]

  • 3. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD, Jin JJ, Maxwell JA, Fukuchi K.
    Immunol Lett; 2007 Sep 15; 112(1):30-8. PubMed ID: 17686533
    [Abstract] [Full Text] [Related]

  • 4. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD, Kong FK, Cao Y, Lewis TL, Kim H, Tang DC, Fukuchi K.
    Neurosci Lett; 2004 Nov 11; 370(2-3):218-23. PubMed ID: 15488326
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL, Currie JR, Mehta PD, Potempska A, Hwang YW, Wegiel J.
    Biochemistry; 2003 Oct 14; 42(40):11682-92. PubMed ID: 14529278
    [Abstract] [Full Text] [Related]

  • 7. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
    DaSilva KA, Brown ME, McLaurin J.
    Vaccine; 2009 Feb 25; 27(9):1365-76. PubMed ID: 19150380
    [Abstract] [Full Text] [Related]

  • 8. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
    Xing X, Sha S, Li Y, Zong L, Jiang T, Cao Y.
    J Neurol Sci; 2012 Feb 15; 313(1-2):17-21. PubMed ID: 22029939
    [Abstract] [Full Text] [Related]

  • 9. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J, Yao Z, Zhang G, Wang H, Xu J, Yew DT, Forster EL.
    J Neurol Sci; 2008 Sep 15; 272(1-2):87-98. PubMed ID: 18571202
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
    Bach P, Tschäpe JA, Kopietz F, Braun G, Baade JK, Wiederhold KH, Staufenbiel M, Prinz M, Deller T, Kalinke U, Buchholz CJ, Müller UC.
    J Immunol; 2009 Jun 15; 182(12):7613-24. PubMed ID: 19494285
    [Abstract] [Full Text] [Related]

  • 13. Immunization with amyloid-beta using GM-CSF and IL-4 reduces amyloid burden and alters plaque morphology.
    DaSilva K, Brown ME, Westaway D, McLaurin J.
    Neurobiol Dis; 2006 Aug 15; 23(2):433-44. PubMed ID: 16766202
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A highly specific antibody response after protein prime-peptide boost immunization with Eppin/B-cell epitope in mice.
    Chen Z, He W, Wu Y, Yan P, He H, Zhang J, Yang X, Shen Z, Liang Z, Li J.
    Hum Vaccin; 2011 Aug 15; 7(8):849-55. PubMed ID: 21817855
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
    Zota V, Nemirovsky A, Baron R, Fisher Y, Selkoe DJ, Altmann DM, Weiner HL, Monsonego A.
    J Immunol; 2009 Sep 01; 183(5):3522-30. PubMed ID: 19675171
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system.
    Vollmar P, Kullmann JS, Thilo B, Claussen MC, Rothhammer V, Jacobi H, Sellner J, Nessler S, Korn T, Hemmer B.
    J Immunol; 2010 Nov 15; 185(10):6338-47. PubMed ID: 20943998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.